Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Fujifilm Diosynth Biotechnologies

Request full access

Fujifilm Diosynth Biotechn, contract development & manufacturing provider for preclinical, clinical and commercial biologics manufacturing

Billingham, United KingdomFounded 1923Health

About Fujifilm Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies operates as a Contract Development and Manufacturing Organization (CDMO) specializing in the biopharmaceutical sector. The company collaborates strategically with biopharmaceutical and biotech companies to develop and manufacture biologics, advanced therapies, and vaccines. Their core services include technical leadership in cell culture, microbial fermentation, and cell and gene therapy, supported by state-of-the-art cGMP (current Good Manufacturing Practice) manufacturing facilities. FUJIFILM Diosynth Biotechnologies serves clients across various clinical phases, from initial clinical process development for cGMP drug substance and drug product manufacturing in Phase I and II, to process optimization, scaling, and characterization in Phase III. The company aims to build long-term partnerships based on trust and mutual success, encapsulated in their 'Partners for Life' philosophy. Their business model revolves around providing comprehensive development and manufacturing solutions, thereby enabling their clients to bring innovative therapies to market efficiently. Revenue is generated through service contracts with biopharmaceutical and biotech companies, focusing on the development and production of high-value biologics and therapies.

Source: Dealroom company data

Fujifilm Diosynth Biotechnologies in the Billingham ecosystem

Live from Dealroom

The Fujifilm Diosynth Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • FUJIFILM
Team profiled 27 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
33 countries with
team presence
🇺🇸 United States41.6%
🇩🇰 Denmark38%
🇬🇧 United Kingdom16.7%
🇮🇪 Ireland1.1%
🇷🇴 Romania0.7%
Top 5 of 33 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Fujifilm Diosynth Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Fujifilm Diosynth Biotechnologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.